New York State Common Retirement Fund Sells 94,515 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

New York State Common Retirement Fund lessened its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 24.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 287,332 shares of the company’s stock after selling 94,515 shares during the quarter. New York State Common Retirement Fund owned approximately 0.16% of Option Care Health worth $9,680,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Vanguard Group Inc. increased its position in Option Care Health by 11.8% in the third quarter. Vanguard Group Inc. now owns 19,319,352 shares of the company’s stock worth $624,981,000 after buying an additional 2,037,162 shares during the last quarter. Third Point LLC increased its holdings in Option Care Health by 55.7% in the 3rd quarter. Third Point LLC now owns 5,450,659 shares of the company’s stock worth $176,329,000 after acquiring an additional 1,950,659 shares during the last quarter. Assenagon Asset Management S.A. purchased a new stake in Option Care Health in the 3rd quarter worth about $36,239,000. Fiera Capital Corp bought a new stake in Option Care Health in the 3rd quarter valued at about $21,370,000. Finally, Riverbridge Partners LLC lifted its holdings in Option Care Health by 49.5% during the fourth quarter. Riverbridge Partners LLC now owns 1,792,012 shares of the company’s stock valued at $60,373,000 after purchasing an additional 593,706 shares during the last quarter. Institutional investors own 98.05% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. Barrington Research reiterated an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a research note on Wednesday, April 24th. Jefferies Financial Group lifted their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the company a “buy” rating in a research note on Monday, March 4th.

Option Care Health Stock Up 0.3 %

Shares of NASDAQ OPCH opened at $29.98 on Thursday. The company has a quick ratio of 1.39, a current ratio of 1.77 and a debt-to-equity ratio of 0.74. The company has a market cap of $5.21 billion, a P/E ratio of 19.72, a P/E/G ratio of 1.48 and a beta of 1.22. Option Care Health, Inc. has a 52 week low of $24.23 and a 52 week high of $35.74. The business has a 50-day simple moving average of $31.75 and a two-hundred day simple moving average of $31.44.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Tuesday, April 23rd. The company reported $0.26 EPS for the quarter, beating analysts’ consensus estimates of $0.22 by $0.04. The company had revenue of $1.15 billion during the quarter, compared to analyst estimates of $1.10 billion. Option Care Health had a net margin of 6.15% and a return on equity of 18.92%. Option Care Health’s revenue was up 12.8% compared to the same quarter last year. During the same period last year, the business earned $0.21 earnings per share. Research analysts anticipate that Option Care Health, Inc. will post 1.18 earnings per share for the current fiscal year.

Insider Activity

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 35,000 shares of the stock in a transaction that occurred on Monday, February 26th. The shares were bought at an average price of $31.55 per share, for a total transaction of $1,104,250.00. Following the completion of the transaction, the director now owns 269,528 shares of the company’s stock, valued at approximately $8,503,608.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.64% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.